HIGHLIGHTS
- who: Filipa Quintela Vieira and collaborators from the Department of Pathological, Cytological and Thanatological Anatomy, Departamento Quu00edmica Bioquu00edmica, Universidade do have published the paper: The Impact of [C16Pyr][Amp] on the Aggressiveness in Breast and Prostate Cancer Cell Lines, in the Journal: (JOURNAL)
- what: The authors focused on members from the imidazolium and pyridinium classes as anticancer compounds: [Amp] (3-(2-hydroxyethyl)-1-methyl-1H-imidazol-3-ium ampicillinate) and_[C16Pyr][Amp] (1-hexadecylpyridin-1-ium ampicillinate) . Considering the promising applications of both ILs and quinoxalines in biomedical research and the pharmaceutical industry, the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.